""	"submission_name"	"submission_date"	"template_name"	"tissue_type"	"response_agent_original"	"response_agent"	"proterm_and_extra"	"fully_qualified_response_agent"	"response_behavior_type"	"response_behavior"	"subgroup"	"time_point"	"time_point_units"	"vaccine_year"	"exposure_material_text"	"exposure_material"	"additional_exposure_material"	"comparison"	"baseline_time"	"cohort"	"publication_reference"	"publication_year"	"signature_source"	"comment"	"publication_reference_url"	"subObsID"	"uniqObsID"	"target_pathogen_1"	"target_pathogen_2"	"target_pathogen_3"	"signature_file"
"subject"	""	""	""	"cell_subset"	""	"cell_subset"	""	""	""	""	""	""	""	""	""	"vaccine"	""	""	""	""	""	""	""	""	""	""	""	"pathogen"	"pathogen"	"pathogen"	""
"evidence"	""	""	""	""	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"url"	"label"	"label"	""	""	""	"file"
"role"	""	""	""	"tissue"	"observed"	"cell_biomarker"	"observed"	"observed"	"background"	"measured"	"background"	"observed"	"observed"	"background"	"background"	"vaccine"	"background"	"background"	"background"	"observed"	"background"	"background"	"background"	"background"	"reference"	"background"	"background"	"pathogen"	"pathogen"	"pathogen"	"observed"
"mime_type"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"numeric_units"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"display_text"	""	""	""	"tissue type"	"response agent (original)"	"response agent (cell subset)"	"cell type PRO and extra terms"	"all response agents in signature"	"response behavior type"	"response behavior"	"subgroup"	"time point"	"time point units"	"vaccine year"	"exposure material (name)"	"exposure material (VO)"	"additional exposure material"	"comparison"	"baseline time"	"cohort"	"publication reference (PMID)"	"publication year"	"Figure or table or text section containing signature"	"comment"	"Gon√ßalves et al. (2020) Innate gene signature distinguishes humoral versus cytotoxic responses to influenza vaccination. J. Clin. Invest. PMID: <a href = 'https://www.ncbi.nlm.nih.gov/pubmed/?term=30843873' target='_blank'>30843873</a>"	"ID of observation within its submission"	"Uniq ID of observation within submission type"	"target pathogen 1"	"target pathogen 2"	"target pathogen 3"	"signature response agents file"
""	"20200421-hipciof_ctf_30843873"	"2020.04.21"	"hipciof_ctf_28"	"serum"	"T cells TIV-specific CD8+ granzyme B+"	"CD8-positive, alpha-beta T cell"	"& granzyme B+, TIV-specific"	"CD8-positive, alpha-beta T cell & granzyme B+, TIV-specific"	"cell type frequency"	"up"	"subjects 2"	"21"	"days"	"2012"	"2012-2013 seasonal trivalent inactivated influenza vaccine (TIV)"	"VO_0004899"	""	"21d-0d"	"time of vaccination (first dose)"	"Adults (18-45)"	"30843873"	"2019"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/30843873"	"1"	"130"	"influenza A virus (A/California/7/2009(H1N1))"	"influenza A virus (A/Victoria/361/2011(H3N2))"	"influenza B virus (B/Wisconsin/01/2010)"	"hipciof_ctf_30843873_130.txt"
""	"20200421-hipciof_ctf_30843873"	"2020.04.21"	"hipciof_ctf_28"	"serum"	"T cell responder TIV-specific CD8+ GRZ+"	"CD8-positive, alpha-beta T cell"	"& GZMB+, TIV-specific"	"CD8-positive, alpha-beta T cell & GZMB+, TIV-specific"	"cell type frequency"	"up"	"cluster 2"	"21"	"days"	"2012"	"2012-2013 seasonal trivalent inactivated influenza vaccine (TIV)"	"VO_0004899"	""	"21d-0d"	"time of vaccination (first dose)"	"Adults (18-45)"	"30843873"	"2019"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/30843873"	"2"	"131"	"influenza A virus (A/California/7/2009(H1N1))"	"influenza A virus (A/Victoria/361/2011(H3N2))"	"influenza B virus (B/Wisconsin/01/2010)"	"hipciof_ctf_30843873_131.txt"
